How can camera images be used during minimally invasive surgeries to assess whether the operated organ is sufficiently perfused with blood? Scientists from the German Cancer Research Center (DKFZ) and the Städtisches Klinikum Karlsruhe have now succeeded in automatic monitoring of ischemia during a kidney surgery using only the optical properties of the tissue and not relying on injection of contrast agent.

A novel, both environmentally friendly and cost-saving process for the production of carbon fibers from lignin has been developed at DITF. It is characterized by high energy-saving potential. The avoidance of solvents and the use of natural raw materials make the process environmentally friendly.

Expert interview - 08/03/2023

How do new active substances from university research reach patients?

Access to capital remains one of the biggest challenges in the life sciences sector. Over the last two years, the Baden-Württemberg Center for Academic Drug Discovery (BWCAD2) has successfully implemented a model of cooperation between academic drug research and industry for the development and validation of therapeutic concepts. Dr. Barbara Jonischkeit spoke with the initiator and leading figure behind the BWCAD2 project, Prof. Dr. Stefan Laufer

In February, the Estonian-based startup New Standard Oil successfully commissioned their first industrial-scale prototype for drying and torrefaction of biogenic feedstock operating with superheated steam at atmospheric pressure.

Bacteria of the species Pseudomonas aeruginosa are antibiotic-resistant hospital germs that can enter blood, lungs and other tissues through wounds and cause life-threatening infections. In a joint project, researchers from the Universities of Freiburg and Strasbourg in France have discovered a mechanism that likely contributes to the severity of P. aeruginosa infections.

Researchers at the University of Freiburg have examined how mulching at different times affects insect flower-visitors and larvae.

Immune complexes in COVID-19 - 01/03/2023

Vicious circle of hyperinflammation

Whether a person experiences only a mild malaise or a critical course of disease after a coronavirus infection apparently depends on the antigen-antibody complexes that form in our body. The discovery of these immune complexes set a group of researchers, headed up by Prof. Dr. Hartmut Hengel from the Freiburg University Medical Centre, on the trail of a vicious circle of constantly escalating inflammation.

The Tech4Biowaste database will be showcased online by its developers on 30 March 2023

Start for an EU-wide collaborative project: Under the leadership of the French company Fairbrics SAS, 17 project partners from 7 European countries are coming together. The common goal is to produce end products from polyester in a closed cycle using industrial CO2 emissions and to bring them to market maturity. The DITF produce synthetic fibers from plastics of non-fossil origin.

nova-Institute’s take on the recently published EU proposal for a Packaging and Packaging Waste Regulation as well as the new policy framework for biobased, biodegradable and compostable plastics.

On February 16, 2023, Baden-Württemberg’s Minister of Science, Research and the Arts, Petra Olschowski, visited the University of Freiburg. The focus of her visit was on sustainability and the transfer of knowledge. The minister learned all about how the day-to-day running of the university is becoming sustainable, and the wide-ranging climate protection and environmental safety measures. She also visited the livMatS pavilion.

Think Tank FYI: Agriculture 5.0 - 16/02/2023

Agriculture 5.0: fighting the climate crisis with agrophotovoltaics and biochar

Climate protection, agriculture and biodiversity are closely intertwined. Agriculture 5.0 provides positive guidance, as the Offenburg University of Applied Sciences has demonstrated: agrophotovoltaics (or agrivoltaics), which is currently in vogue in Germany, can be used to generate solar power on high-yield fields. Biomass strips and biochar remove CO2 from the atmosphere. All this improves soil quality and promotes biodiversity.

Around 7 million euros to promote more sustainable use of the world's limited phosphate supply: The German-Chinese Research Training Group AMAIZE-P can continue its research on phosphorus as one of the most important nutrient elements for plants. The German Research Foundation (DFG) has approved a second funding period of another 4.5 years.

Cytolytics GmbH - 14/02/2023

Bioinformatics meets medical diagnostics and drug development

The start-up company Cytolytics from Tübingen has developed a robust and user-friendly software platform that uses machine learning for the automated analysis of cells. This is beneficial in areas such as cancer diagnostics and the development of new pharmaceutically active substances.

Review - 09/02/2023

5th Gene Technology Report – a critical observation of a cutting-edge technology

The societal importance of genetic technologies was demonstrated during the coronavirus pandemic, when it was possible to rapidly develop suitable vaccines thanks to genetic engineering methods. As a result, the Fifth Gene Technology Report published in autumn 2021 reads like a validation of many years of work, as well as making it clear that the will to continue the detailed long-term monitoring is very much present.

Review - 09/02/2023

5th Gene Technology Report – a critical observation of a cutting-edge technology

The societal importance of genetic technologies was demonstrated during the coronavirus pandemic, when it was possible to rapidly develop suitable vaccines thanks to genetic engineering methods. As a result, the Fifth Gene Technology Report published in autumn 2021 reads like a validation of many years of work, as well as making it clear that the will to continue the detailed long-term monitoring is very much present.

This month marks the launch of an outstanding project integrating artificial intelligence (AI) and neuromedicine – the Hertie Institute for Artificial Intelligence in Brain Health (Hertie AI). Founded on February 1 at the Medical Faculty of the University of Tübingen, it will be the first institute in Germany to research the prevention and early diagnosis of diseases of the nervous system using artificial intelligence methods.

Patients have 30 percent fewer serious side effects when medication doses are tailored to their genetic profile. This is what an international research consortium has found out, including the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology at the Bosch Health Campus. With an individual DNA medication pass, as used in the study, treatments can be made more effective and safer in the future.

Non-profit limited liability company creates institutional framework for interdisciplinary research collaboration, innovative technology development and outstanding healthcare in the Rhine-Neckar region.

Synergistic effects with microalgae and purple bacteria - 03/02/2023

Working towards a hydrogen economy with a wastewater biorefinery: the SmartBioH2-BW project

A biorefinery that uses industrial wastewater and residual material streams is being built in Rheinfelden (Baden). It will have two interlinking bioreactors and will synthesize biohydrogen as well as organic basic materials such as carotenoids and proteins. SmartBioH2-BW is a pilot project run by the Urban and Industrial Biorefineries initiative and funded by the Baden-Württemberg Ministry of the Environment, Climate Protection and Energy Sector.

Photon-counting technology - 01/02/2023

PC3 consortium: innovative computed tomography for Baden-Württemberg

The University Hospitals of Freiburg, Tübingen and Mannheim have been cooperating with each other since 2021 to test new types of computed tomography devices. With the help of photon-counting technology, the aim is not only to improve patient care, but also to encourage local companies to develop downstream data processing technologies.

In the 2022 allocation round for the award of the prestigious Consolidator Grants of the European Research Council, researchers of Karlsruhe Institute of Technology (KIT) have been successful. For their projects in the fields of photovoltaics and medical sensor technology, physicist Ulrich W. Paetzold and chemist Frank Biedermann will receive approximately two million euros over the next five years.